Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...
Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...
Healthcare Asia Magazine on MSN3d
Global cell and gene therapy market to reach $76b in 2030It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
13d
ExtremeTech on MSNNew Gene Therapy Cures Man's Sickle Cell AnemiaA 21-year-old man has become the first person in New York—and one of the first in the world—to be cured of sickle cell anemia ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japan’s Pharmaceuticals and Medical Devices ...
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: ...
The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results